(Q43698829)

English

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia

scientific article published in August 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Baldwin KC

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Ginsberg PC

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Roehrborn CG

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Harkaway RC

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

203-209

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The development of human benign prostatic hyperplasia with age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High prevalence of benign prostatic hypertrophy in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years. Follow-up of the Scandinavian Open-Extension Study. The Scandinavian Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a prostate model to assist in training for digital rectal examination

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin for bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901201-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(01)01201-8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43698829&oldid=2102663513"